Natera, Inc. NTRA

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $309.83
Market Cap $44.52B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑35.9% YoY
$2.31B
3-Yr CAGR: 41.1%
Net Income ↓-9.3% YoY
-$208.16M
Net Margin: -9.0%
Free Cash Flow ↑57.6% YoY
$109.11M
FCF Yield: 0.25%
EPS (Diluted) ↑0.7% YoY
$-1.52
Basic: $-1.52
Return on Equity Efficiency
-12.2%
ROA: -372.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (NTRA)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $217.1M $81.5M $-95.8M $-1.86 $-73.9M $-97.0M
FY 2017 $210.9M -2.8% $75.4M $-136.3M -42.3% $-2.56 -37.6% $-96.8M $-106.7M -9.9%
FY 2018 $257.7M +22.1% $99.6M $-128.2M +6.0% $-2.22 +13.3% $-70.6M $-74.5M +30.2%
FY 2019 $302.3M +17.3% $89.9M $-124.8M +2.6% $-1.79 +19.4% $-63.4M $-68.4M +8.1%
FY 2020 $391.0M +29.3% $87.3M $-229.7M -84.0% $-2.84 -58.7% $-182.5M $-202.1M -195.4%
FY 2021 $625.5M +60.0% $42.9M $-471.7M -105.3% $-5.21 -83.5% $-335.2M $-376.3M -86.2%
FY 2022 $820.2M +31.1% $47.6M $-547.8M -16.1% $-5.57 -6.9% $-431.5M $-479.2M -27.4%
FY 2023 $1,082.6M +32.0% $172.1M $-434.8M +20.6% $-3.78 +32.1% $-247.0M $-286.2M +40.3%
FY 2024 $1,696.9M +56.7% $619.0M $-190.4M +56.2% $-1.53 +59.5% $135.7M $69.2M +124.2%
FY 2025 $2,306.1M +35.9% $867.4M $-208.2M -9.3% $-1.52 +0.7% $215.3M $109.1M +57.6%
$

Valuation

Market Price $309.83
Market Cap $44.52B
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 25.91
FCF Yield 0.25%
Dividend Yield N/A
Shares Outstanding 143,215,400
%

Profitability & Margins

Gross Margin 37.61%
Operating Margin -13.44%
Net Margin -9.03%
Return on Equity (ROE) -12.16%
Return on Assets (ROA) -372.86%
Asset Turnover 41.31x
Revenue 3-Yr CAGR 41.14%
🛡️

Financial Health & Liquidity

Current Ratio 0.13
Cash Ratio 1.06
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $466.00M
Total Debt N/A
Book Value / Share $11.96
💧

Cash Flow Efficiency

Operating Cash Flow $215.30M
Capital Expenditures (CapEx) $106.19M
Free Cash Flow $109.11M
OCF / Revenue 9.34%
FCF / Revenue 4.73%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-1.52
EPS (Basic) $-1.52
Dividends / Share N/A
Book Value / Share $11.96
EPS YoY Growth 0.65%
🏛️

Balance Sheet (FY 2025)

Total Assets $55.83M
Total Liabilities $441.23M
Stockholders' Equity $1.71B
Current Assets $55.83M
Current Liabilities $441.23M